Upcoming events

Hot line - Antithrombotic strategies

Session comprising selected EuroPCR 2015 late-breaking trial submissions

Presentations available when logged in:

  • Antiplatelet and antithrombotic effects during contemporary primary angioplasty for STEMI: observations from the HEAT PPCI platelet substudy
  • Low real-world early stent thrombosis rates in STEMI patients, regardless of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatmen...
  • Anatomical location and bleeding risk as potential drivers of DAPT duration: insights from PRODIGY trial
  • Prasugrel in clopidogrel non-responders: results of the REsponsiveness to CLOpidogrel and Stent-related Events study (RECLOSE 3)
  • Comparing zotarolimus-eluting and bare-metal stent efficacy in selected high bleeding risk patients treated with a short DAPT duration: a pre-speci...
  • Selective intensification of P2Y12 inhibitor therapy based on platelet reactivity, CYP2C19 genotype and clinical risk factors in non-urgent PCI pat...
  • A multicentre registry of consecutive patients undergoing cardiac and non-cardiac surgery or operative endoscopic/endovascular procedures after imp...